-
Publication Date2016-10
Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: Application of DSC perfusion MR imaging
Hye Rim Cho; Bora Hong; Kim H., et al
ONCOTARGET, v.7, no.43, pp.69606 - 69615
-
Publication Date2020-01
Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value
I. Hwang; S.H. Choi; Park C.-K., et al
AMERICAN JOURNAL OF NEURORADIOLOGY, v.41, no.1, pp.49 - 56
-
Publication Date2015-01
Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging
Lee S.; Seung Hong Choi; Ryoo I., et al
JOURNAL OF NEURO-ONCOLOGY, v.121, no.1, pp.141 - 150
-
Publication Date2015-03
Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: Differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR Imaging
Yun T.J.; Park C.-K.; Kim T.M., et al
RADIOLOGY, v.274, no.3, pp.830 - 840